ADMA Biologics ADMA Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's deferred revenue?
- ADMA Biologics (ADMA) reported deferred revenue of $1.37M in Q1 2026.
- How has ADMA Biologics's deferred revenue changed year-over-year?
- ADMA Biologics's deferred revenue increased by 857.3% year-over-year, from $143K to $1.37M.
- What is the long-term trend for ADMA Biologics's deferred revenue?
- Over 5 years (2020 to 2025), ADMA Biologics's deferred revenue has grown at a 58.0% compound annual growth rate (CAGR), from $142.83K to $1.41M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.